Back to News
Market Impact: 0.55

Altria Rises 12% in 3 Months: Should You Buy, Sell or Hold the Stock?

MOPMTPBBTI
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsMarket Technicals & FlowsAnalyst InsightsConsumer Demand & RetailCapital Returns (Dividends / Buybacks)Investor Sentiment & Positioning
Altria Rises 12% in 3 Months: Should You Buy, Sell or Hold the Stock?

Altria Group (MO) stock gained 11.8% over the past three months, significantly outperforming the S&P 500 and the broader tobacco sector, driven by robust second-quarter 2025 results. The company reported an 8.3% rise in adjusted EPS to $1.44, fueled by higher pricing, operational efficiencies, and strong momentum in its smoke-free segment, particularly with "on!" nicotine pouch shipments surging 26.5%. This strategic shift towards reduced-risk products, coupled with resilient performance in its traditional smokeable segment and an attractive forward P/E ratio of 11.81, positions Altria as a compelling opportunity for investors seeking value and growth in a challenging market.

Analysis

Altria (MO) stock surged 11.8% over the past three months, significantly outperforming the S&P 500's 8% growth and contrasting with declines in the broader Zacks Consumer Staples (-4.3%) and Tobacco (-4.8%) sectors. This strong performance, with MO trading above its 200-day moving average, signals bullish sentiment despite mixed peer performance. The rally is underpinned by robust Q2 2025 results, where adjusted EPS rose 8.3% year-over-year to $1.44, driven by higher pricing and operational efficiencies. Revenues, net of excise taxes, remained steady at $5.29 billion. Management subsequently raised the lower end of its 2025 adjusted EPS guidance to $5.35-$5.45, projecting 3-5% growth. A key growth driver is the smoke-free segment, with 'on!' nicotine pouch shipments jumping 26.5% year-over-year to 52.1 million cans, increasing its retail share to 8.7% and boosting adjusted operating income by 10.9%. Concurrently, the smokeable products segment demonstrated resilience, with adjusted operating income growing 4.2% and margins widening 290 basis points to 64.5%, as Marlboro maintained its 59.5% premium market share. Altria's valuation appears attractive, trading at a forward 12-month P/E ratio of 11.81, below the industry average of 14.51 and significantly lower than peers like Philip Morris (19.39) and Turning Point Brands (24.65). This relative discount, combined with a Zacks Rank #2 (Buy) rating, suggests a compelling value opportunity.